Daesang Corporation said North American sales of allulose increased 450% year over year in 2025, while its customer network grew to about 30 companies, as it expands its sugar-reduction business beyond South Korea.
In its Oct. 16 announcement, Daesang cited demand from beverage, dairy, confectionery, nutrition and sauce makers.
Daesang is positioning Sweevero, its global sugar-reduction brand, as a way for food manufacturers to develop lower-sugar products. Launched in 2024, the brand brings together allulose and other sweeteners in blends tailored to manufacturers’ products, along with technology intended to adjust taste, the company said.
Daesang describes allulose as a rare sugar. It says the ingredient is about 70% as sweet as sugar, with calories at roughly 10% of sugar’s level. The company linked its expansion to consumer interest in reducing sugar intake and changes in eating patterns associated with GLP-1 medications.
“Demand for allulose is rising rapidly,” said Hyo-hoon Lee, Daesang’s head of Ingredient Marketing. The company says its U.S. subsidiary helps North American customers.
Daesang’s allulose facility is part of its starch and sweetener complex in Gunsan, South Korea. The company said its investment in the facility was about KRW 30 billion, made in July 2023, and that the site supports supply and quality.
The company dates its entry into the North American allulose market to 2023. Seoul Economic Daily reported in January that local marketing began in 2024 and U.S. sales followed in 2025.
Daesang plans to pursue business in Canada, Latin America, Europe, Japan and Southeast Asia. It is also exploring additional capacity and possible local manufacturing in key markets, but has not given a timetable or investment estimate.
